Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
47,716,968
-
Share change
-
-2,680,519
-
Total reported value
-
$4,602,865,798
-
Put/Call ratio
-
193%
-
Price per share
-
$96.43
-
Number of holders
-
639
-
Value change
-
-$270,760,497
-
Number of buys
-
205
-
Number of sells
-
331
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2018
As of 31 Dec 2018,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
639 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,716,968 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, DEUTSCHE BANK AG\, GOLDMAN SACHS GROUP INC, CITIGROUP INC, JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, and NATIXIS.
This page lists
642
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.